SynthesisBMC infectious diseases2026
Quality of tuberculosis diagnostic laboratories in Ethiopia assessed through External Quality Assessment components: a systematic review.
Synthesis in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReliable tuberculosis (TB) diagnosis is central to TB control programs, particularly in high-burden countries such as Ethiopia. External Quality Assessment (EQA) is a core component of laboratory quality assurance, encompassing blinded rechecking, panel testing, and on-site evaluation. This systematic review aimed to evaluate the quality of tuberculosis diagnostic laboratories in Ethiopia through EQA components and to synthesize evidence on laboratory performance, error patterns, and associated factors.
methodsA systematic review of published studies conducted in Ethiopia was performed. Seventeen original articles published between 2005 and 2025 were included. All studies assessed TB diagnostic laboratory quality using one or more EQA components. Data were extracted on study characteristics, EQA methods, performance indicators (sensitivity, specificity, agreement), error rates, and determinants of quality. A narrative synthesis approach was employed.
resultsSeventeen studies (n = 17) conducted between 2005 and 2025 met the inclusion criteria. EQA methods included blinded rechecking (n = 15), panel testing (n = 13), and on-site evaluation (n = 12). Reported sensitivity ranged from 83.5% to 96.6%, and specificity from 92.9% to 99.7%. Agreement between peripheral and reference laboratories was consistently high (κ = 0.60–0.97). Major errors, particularly high false negatives, were reported in several regions and were associated with poor smear quality, lack of internal quality control, inadequate training, reagent shortages, and absence of regular EQA participation. Decentralized and sustained EQA implementation demonstrated measurable improvements in laboratory performance over time.
conclusionExternal Quality Assessment has substantially improved the quality of TB diagnostic laboratories in Ethiopia; however, persistent technical, infrastructural, and human resource gaps remain. Strengthening EQA coverage, integrating internal quality control, and continuous capacity building are essential to ensure reliable TB diagnosis and support national TB control efforts. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.